Latest Neuroblastoma Stories
Survivors of childhood cancers are at an increased risk of another battle with cancer later in life.
The Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare have conducted whole genome sequencing (WGS) of a rare nasal tract cancer called olfactory neuroblastoma (ONB).
An inexpensive "orphan drug" used to treat sleep disorders appears to be a potent inhibitor of cancer cells.
The American Society of Clinical Oncology (ASCO) today highlighted five studies in a press briefing from among more than 4,500 abstracts publicly posted online at abstract.asco.org in advance of ASCO's 47th Annual Meeting.
A pill designed to zero in on abnormal genes that drive specific cancers has produced encouraging early results in children with an uncommon but aggressive type of lymphoma, as well as in children with a rare form of neuroblastoma.
For the first time, scientists at Fred Hutchinson Cancer Research Center have transplanted brain cancer patients' own gene-modified blood stem cells in order to protect their bone marrow against the toxic side effects of chemotherapy.
Ongoing research by a Baylor College of Medicine pediatric oncologist to understand how special cells called natural killer T (NKT) cells can be used to suppress neuroblastoma tumor growth has led to the discovery that the protein IL-15 is key to protecting the NKT cells' anti-tumor effectiveness in a hostile environment.
- In medieval musical notation, a sign or neume denoting a shake or trill.